v3.26.1
Share-Based Payment Awards (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock Option Activity Under Plan

The following table provides a reconciliation of stock option activity under the Company’s equity incentive plan and for inducement awards for the six months ended June 30, 2026:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding at December 31, 2025

 

 

9,665,842

 

 

$

11.54

 

 

 

7.38

 

 

 

73,168

 

Granted

 

 

3,027,416

 

 

 

16.40

 

 

 

 

 

 

 

Exercised

 

 

(168,443

)

 

 

7.14

 

 

 

 

 

 

 

Forfeited

 

 

(376,506

)

 

 

12.23

 

 

 

 

 

 

 

Expired

 

 

(58,828

)

 

 

21.11

 

 

 

 

 

 

 

Outstanding at June 30, 2026

 

 

12,089,481

 

 

$

12.75

 

 

 

7.55

 

 

$

41,432

 

Exercisable at June 30, 2026

 

 

6,326,143

 

 

$

11.64

 

 

 

6.30

 

 

$

28,608

 

Schedule of Key Assumptions Used

The fair value of the share-based awards was measured with the following range of assumptions for the six months ended June 30, 2026:

 

 

Six Months Ended

 

 

June 30, 2026

Option life (in years)

 

5.5 - 6.1

Stock volatility

 

96% - 99%

Risk-free interest rate

 

3.68% - 4.31%

Expected dividends

 

0.0%

Summary of Information about Stock Options

The following table summarizes information about employee, non-executive director and external consultant stock options for the six months ended June 30, 2026 (in thousands except per share amount):

Six Months Ended

 

June 30, 2026

 

Weighted average grant date fair value per share

$

13.12

 

Total cash received from exercise of stock options

 

1,203

 

Total intrinsic value of stock options exercised

 

1,323

 

Summary of Restricted Stock Unit Activity

The following table provides a reconciliation of RSU activity under the 2016 Plan and the 2023 Plan for the six months ended June 30, 2026:

 

 

Number of Restricted Stock Units

 

 

Weighted Average Grant Date Fair Value

 

Nonvested at December 31, 2025

 

 

1,473,538

 

 

$

10.37

 

Granted

 

 

898,119

 

 

 

17.48

 

Vested

 

 

(704,086

)

 

 

9.63

 

Forfeited

 

 

(57,945

)

 

 

13.47

 

Nonvested at June 30, 2026

 

 

1,609,626

 

 

$

14.55

 

Compensation Expense from Stock-Based Payment Awards

The Company’s condensed consolidated statements of operations and comprehensive loss included total compensation expense from stock-based payment awards as follows (in thousands):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Compensation expense included in:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

6,047

 

 

$

3,178

 

 

$

12,057

 

 

$

6,642

 

General and administrative

 

 

4,351

 

 

 

3,698

 

 

 

9,979

 

 

 

8,054

 

Total

 

$

10,398

 

 

$

6,876

 

 

$

22,036

 

 

$

14,696